Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals

BMJ Open

Volumn 6, Issue 10, 2016, Pages

  Rehal, Sunita ^a   Morris, Tim P ^a   Fielding, Katherine ^a,b   Carpenter, James R ^a,b   Phillips, Patrick P J ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; INFORMATION CENTER; INTERNAL MEDICINE; MALE; MEDLINE; NON-INFERIORITY TRIAL; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TYPE I ERROR; UNITED STATES; JOURNAL IMPACT FACTOR; MEDICAL RESEARCH; METHODOLOGY; PATIENT SELECTION; PROCEDURES; PUBLICATION; PUBLISHING; STANDARDS; STATISTICAL BIAS; STATISTICS;

BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; GUIDELINES AS TOPIC; HUMANS; JOURNAL IMPACT FACTOR; PATIENT SELECTION; PERIODICALS AS TOPIC; PUBLISHING; RESEARCH DESIGN; SAMPLE SIZE; STATISTICS AS TOPIC;

EID: 85016742312     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/BMJOPEN-2016-012594     Document Type: Article

References (47)

1. Piaggio G, Elbourne DR, Altman DG, et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152-60.
2. Food and Drug Administration, HHS. Draft Guidance for Industry Non-Inferiority Clinical Trials. 2010.
3. Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials 2011;12:106.
4. Treadwell JR, Uhl S, Tipton K, et al. Assessing equivalence and noninferiority. J Clin Epidemiol 2012;65:1144-9.
5. Snapinn SM. Noninferiority trials. Curr Control Trials Cardiovasc Med 2000;1:19-21.
6. Murthy VL, Desai NR, Vora A, et al. Increasing proportion of clinical trials using noninferiority end points. Clin Cardiol 2012;35:522-3.
7. Suda KJ, Hurley AM, McKibbin T, et al. Publication of noninferiority clinical trials: changes over a 20-year interval. Pharmacotherapy 2011;31:833-9.
8. Vermeulen L. Gain in popularity of noninferiority trial design: caveat lector. Pharmacotherapy 2011;31:2.
9. Piaggio G, Elbourne DR, Pocock SJ, et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594-604.
10. Committee for Medicinal Products for Human Use (CHMP) CPMP. Points to consider on switching between superiority and non-inferiority. London, UK, 2000 (cited 3 November 2015). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003658.pdf
11. Committee for Medicinal Products for Human Use, Efficacy Working Party, Committee for Release for Consultation. Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin. Stat Med 2006;25:1628-38.
12. International Conference on Harmonisation; guidance on statistical principles for clinical trials; availability-FDA. Notice. Fed Regist 1998;63:49583-98.
13. Food, Drug Administration HHS. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice. Fed Regist 2001;66:24390-1.
14. Chan AW, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586.
15. GAO. New drug approval. FDA's Consideration of Evidence from Certain Clinical Trials. 2010 (cited 1 April 2016). http://www.gao.gov/assets/310/308301.pdf
16. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
17. D'Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues-the encounters of academic consultants in statistics. Stat Med 2003;22:169-86.
18. Matsuyama Y. A comparison of the results of intent-to-treat, per-protocol, and g-estimation in the presence of non-random treatment changes in a time-to-event non-inferiority trial. Stat Med 2010;29:2107-16.
19. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med 1999;18:1905-42.
20. Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ 2010;340: c2697.
21. ISI Web of Knowledge (cited 31 May 2015). http://admin-apps.webofknowledge.com/JCR/JCR
22. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons, 1987.
23. Hwang IK, Morikawa T. Design issues in noninferiority equivalence trials. Drug Inform J 1999;33:1205-18.
24. Vickers A, Goyal N, Harland R, et al. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998;19:159-66.
25. Hopewell S, Loudon K, Clarke MJ, et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009;(1):MR000006.
26. Tunes da Silva G, Logan BR, Klein JP. Methods for equivalence and noninferiority testing. Biol Blood Marrow Transplant 2009;15(1 Suppl):120-7.
27. Schiller P, Burchardi N, Niestroj M, et al. Quality of reporting of clinical non-inferiority and equivalence randomised trials-update and extension. Trials 2012;13:214.
28. Wangge G, Klungel OH, Roes KC, et al. Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. PLoS ONE 2010;5:e13550.
29. Le Henanff A, Giraudeau B, Baron G, et al. Quality of reporting of noninferiority and equivalence randomized trials. JAMA 2006;295:1147-51.
30. Gallagher TQ, Hill C, Ojha S, et al. Perioperative dexamethasone administration and risk of bleeding following tonsillectomy in children: a randomized controlled trial. JAMA 2012;308:1221-6.
31. Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. N Engl J Med 2015;372:1598-607.
32. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000;32:1008-15.
33. COMET Initiative [cited 2016 July 20th]. http://www.comet-initiative.org/
34. Lesaffre E. Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis 2008;66:150-4.
35. Postma DF, van Werkhoven CH, van Elden LJ, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 2015;372:1312-23.
36. Schulz-Schüpke S, Helde S, Gewalt S, et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA 2014;312:1981-7.
37. Lucas BP, Trick WE, Evans AT, et al. Effects of 2- vs 4-week attending physician inpatient rotations on unplanned patient revisits, evaluations by trainees, and attending physician burnout: a randomized trial. JAMA 2012;308:2199-207.
38. Gülmezoglu AM, Lumbiganon P, Landoulsi S, et al. Active management of the third stage of labour with and without controlled cord traction: a randomised, controlled, non-inferiority trial. Lancet 2012;379:1721-7.
39. Kaji AH, Lewis RJ. Noninferiority trials: is a new treatment almost as effective as another? JAMA 2015;313:2371-2.
40. Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 2016;315:142-9.
41. Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA 2015;314:2641-53.
42. Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALACART randomized clinical trial. JAMA 2015;314:1356-63.
43. Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
44. Wiens BL, Rosenkranz GK. Missing data in noninferiority trials. Stat Biopharm Res 2013;5:383-93.
45. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393.
46. Morris TP, Kahan BC, White IR. Choosing sensitivity analyses for randomised trials: principles. BMC Med Res Methodol 2014;14:11.
47. Vale CL, Tierney JF, Burdett S. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews. BMJ 2013;346:f1798.